Zobrazeno 1 - 10
of 12
pro vyhledávání: '"L. C. J. Dorssers"'
Publikováno v:
Journal of Clinical Oncology. 12:1541-1546
PURPOSE To evaluate polymerase chain reaction (PCR) analysis as a method for the detection of circulating lymphoma cells in patients with stage III and IV t(14; 18)-positive follicular Non-Hodgkin's lymphoma (NHL) in first remission in a longitudinal
Publikováno v:
Growth Factors. 11:93-104
Interleukin-3 (IL-3) is involved in regulation of proliferation and differentiation of multipotent hemopoietic cells and stimulates the production of most blood cell types. The observed functional specificity across species concurs with an extreme ra
Publikováno v:
Blood. 82:2510-2516
Stage I and II follicular non-Hodgkin's lymphoma (NHL) is clinically defined as a localized disease. To study the possibility that this disease is in fact disseminated, we used the sensitive polymerase chain reaction (PCR) method using translocation
Autor:
L. C. J. Dorssers, G. Wagemaker, P. J. Lemson, C. Janssen, M. C. Mostert, R. Van Lambalgen, Herman Burger, R. W. Van Leen
Publikováno v:
Journal of Biological Chemistry. 266:21310-21317
Human interleukin-3 (hIL-3) is a regulator of proliferation and differentiation of multipotent hemopoietic progenitor cells. Mutants of hIL-3 have been constructed by oligonucleotide-directed mutagenesis and expressed in Escherichia coli and Bacillus
Autor:
R. W. Van Leen, F. C. J. M. Van Gils, L. C. J. Dorssers, G. Wagemaker, N. L. M. Persoon, H. Burger, Edward F. Knol, Jonathan L. Heeney, J. J. Wielenga
Publikováno v:
Scopus-Elsevier
Recombinant rhesus monkey interleukin-3 (IL-3) was administered to normal rhesus monkeys in graded doses ranging from 3 to 30 micrograms/kg/d subcutaneously for 30 consecutive days or given as a continuous intravenous infusion at a dose of 30 microgr
Autor:
M. Hoogeveen-Westerveld, P. E. Hupkes, M. B. Van't Veer, D. Doekharan, L. C. J. Dorssers, N. Van Belzen
Publikováno v:
Leukemia, 12, 1810-1816. Nature Publishing Group
Minimal residual disease (MRD) detection in B cell non-Hodgkin's lymphoma (NHL) patients has been shown to be possible using the rearranged heavy (IgH) chain gene as a tumor marker. To explore a second independent tumor marker, we used specific PCR p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8754882bcad885062ac2529733889a9b
https://pure.eur.nl/en/publications/0fb295c4-c36b-4054-b9b0-e96f95cb11fa
https://pure.eur.nl/en/publications/0fb295c4-c36b-4054-b9b0-e96f95cb11fa
Autor:
P. E. Hupkes, D. Doekharan, M. B. Van't Veer, L. C. J. Dorssers, N. Van Belzen, M. Hoogeveen-Westerveld
Publikováno v:
Leukemia, 1742-1752. Nature Publishing Group
ISSUE=11;STARTPAGE=1742;ENDPAGE=1752;ISSN=0887-6924;TITLE=Leukemia
ISSUE=11;STARTPAGE=1742;ENDPAGE=1752;ISSN=0887-6924;TITLE=Leukemia
Rearranged immunoglobulin heavy chain (IgH) genes provide unique clonal markers for B cells. Since amplification of the rearranged gene by polymerase chain reaction (PCR) and demonstrating that the amplified sequence is indeed derived from tumor cell
Autor:
L. C. J. Dorssers, R. W. Van Leen, Gerard Wagemaker, N. L. M. Persoon, P. J. Lemson, B. Noordam, J. G. Bakhuis, R. F. W. C. van Beckhoven, R. W. J. Hommes, Herman Burger
Publikováno v:
Bio/technology (Nature Publishing Company). 9(1)
We expressed a cDNA encoding the multicolony stimulating factor interleukin-3 in a variety of cell types, including bacteria, yeast and mammalian cells. After evaluation of the advantages and disadvantages of each potential system, we designed a prod
Publikováno v:
Nucleic acids research. 18(22)
Autor:
G. Wagemaker, Herman Burger, N. L. M. Persoon, P. J. Lemson, L. C. J. Dorssers, R. W. Van Leen
Publikováno v:
Blood, 11, 76, 2229-2234
To enable preclinical studies on homologous interleukin-3 (IL-3) in primate species, we isolated the gene encoding Rhesus monkey IL-3 (RhIL- 3). The nucleotide sequence of the RhIL-3 gene displayed 92.9% homology with that of the human IL-3 (hIL-3) g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ce810f751bf16f73b95338c5aee3c3d
http://resolver.tudelft.nl/uuid:9731cba0-421e-4429-ae8e-f5a8723ac548
http://resolver.tudelft.nl/uuid:9731cba0-421e-4429-ae8e-f5a8723ac548